Advertisement

Endocrine

pp 1–8 | Cite as

Association between vitamin D receptor gene polymorphisms and Graves’ disease: a systematic review and meta-analysis

  • Stavroula Veneti
  • Panagiotis AnagnostisEmail author
  • Fotini Adamidou
  • Aikaterini-Maria Artzouchaltzi
  • Kostas Boboridis
  • Marina Kita
Meta-Analysis

Abstract

Purpose

The pathogenesis of Graves’ disease (GD) and orbitopathy (GO) is not completely elucidated. On the other hand, vitamin D receptor (VDR) gene polymorphisms have been associated with vulnerability to a plethora of chronic autoimmune diseases. The primary aim of this study was to synthesize evidence on the association between VDR gene polymorphisms and GD. Secondary aim was to investigate their association with GO.

Methods

A comprehensive search was conducted in PubMed, CENTRAL and Scopus, up to December 8, 2018. Data were expressed as odds ratio (OR) with 95% confidence intervals (CI). Heterogeneity was quantified with I2 index.

Results

Ten studies were included in the qualitative and quantitative analysis. TT subtype of TaqI polymorphism was associated with an increased risk of GD compared with Tt and tt polymorphisms (OR: 1.42; 95% CI, 1.05–1.94, p = 0.025), whereas tt was associated with a lower risk of GD, compared with TT and Tt polymorphisms (OR: 0.79; 95% CI, 0.62-0.99, p = 0.043). No association was found for ApaI, BsmI, and FokI polymorphisms. The bb subtype of BsmI polymorphism was associated with a lower risk in Asian, but with a higher GD risk in Caucasian populations, compared with BB/Bb subtypes. No eligible study was found regarding the association between VDR gene polymorphisms and the risk of GO.

Conclusions

The TT subtype of the TaqI polymorphism was associated with a higher susceptibility for GD compared with Tt and tt. Regarding BsmI, the bb subtype was associated with increased GD risk in Caucasians, whereas it is protective in Asians.

Keywords

Vitamin D receptor VDR Gene Polymorphisms Graves’ disease 

Notes

Author contributions

S.V. searched the literature, extracted and analyzed the data and wrote the first draft of the paper with P.A., who also designed the study and resolved discrepancies regarding the quality of the studies. A.-M.A. extracted and analyzed the data. F.A., K.B., and M.K. reviewed the manuscript and provided critical scientific input.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

12020_2019_1902_MOESM1_ESM.doc (50 kb)
Supplementary Table 1.
12020_2019_1902_MOESM2_ESM.doc (41 kb)
Supplementary Table 2.
12020_2019_1902_MOESM3_ESM.docx (15 kb)
Supplementary Table 3.

References

  1. 1.
    P. Anagnostis, F. Adamidou, S.A. Polyzos, S. Katergari, E. Karathanasi, C. Zouli, A. Panagiotou, M. Kita, Predictors of long-term remission in patients with Graves' disease: a single center experience. Endocrine 44, 448–453 (2013)CrossRefPubMedGoogle Scholar
  2. 2.
    W. Horst-Sikorska, M. Ignaszak-Szczepaniak, M. Marcinkowska, M. Kaczmarek, M. Stajgis, R. Slomski, Association analysis of vitamin D receptor gene polymorphisms with bone mineral density in young women with Graves' disease. Acta Biochim. Pol. 55, 371–380 (2008)PubMedGoogle Scholar
  3. 3.
    M. Stefanić, I. Karner, L. Glavas-Obrovac, S. Papić, D. Vrdoljak, G. Levak, B. Krstonosić, Association of vitamin D receptor gene polymorphism with susceptibility to Graves' disease in Eastern Croatian population: case-control study. Croat. Med. J. 46, 639–646 (2005)PubMedGoogle Scholar
  4. 4.
    J.E. Collins, J.M. Heward, R. Nithiyananthan, S. Mejentsev, J.A. Todd, J.A. Franklyn, S.C.L. Gough, Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians. Clin. Endocrinol. (Oxf.). 60, 618–624 (2004)CrossRefPubMedGoogle Scholar
  5. 5.
    A. Lombardi, F. Menconi, D. Greenberg, E. Concepcion, M. Leo, R. Rocchi, M. Marinó, M. Keddache, Y. Tomer, Dissecting the genetic susceptibility to Graves' disease in a cohort of patients of Italian origin. Front. Endocrinol. (Lausanne). 7, 21 (2016)CrossRefPubMedGoogle Scholar
  6. 6.
    E. Ramos-Lopez, A. Kurylowicz, T. Bednarczuk, J. Paunkovic, C. Seidl, K. Badenhoop, Vitamin D receptor polymorphisms are associated with Graves' disease in German and Polish but not in Serbian patients. Thyroid 15, 1125–1130 (2005)CrossRefPubMedGoogle Scholar
  7. 7.
    P. Anagnostis, K. Boboridis, F. Adamidou, M. Kita, Natural course of mild Graves' orbitopathy: is it a chronic remitting or a transient disease? J. Endocrinol. Invest. 40, 257–261 (2017)CrossRefPubMedGoogle Scholar
  8. 8.
    N. Inoue, M. Watanabe, N. Ishido, Y. Katsumata, T. Kagawa, Y. Hidaka, Y. Iwatani, The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases. Clin. Exp. Immunol. 178, 262–269 (2014)CrossRefPubMedGoogle Scholar
  9. 9.
    W. Dankers, E.M. Colin, J.P. van Hamburg, E. Lubberts, Vitamin D in autoimmunity: molecular mechanisms and therapeutic potential front. Immunol. 7, 697 (2017)Google Scholar
  10. 10.
    S. Chen, G.P. Sims, X.X. Chen, Y.Y. Gu, S. Chen, P.E. Lipsky, Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 179, 1634–1647 (2007)CrossRefPubMedGoogle Scholar
  11. 11.
    D.M. Provvedini, C.D. Tsoukas, L.J. Deftos, S.C. Manolagas, 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221, 1181–1183 (1983)CrossRefPubMedGoogle Scholar
  12. 12.
    M. Umar, K.S. Sastry, A.I. Chouchane, Role of vitamin D Beyond the skeletal function: a review of the molecular and clinical studies. Int. J. Mol. Sci. 19, pii: E1618 (2018)CrossRefGoogle Scholar
  13. 13.
    S. El Gawad, E. Samee, A. Metwali, M. El Gawad, Vitamin D receptor gene polymorphism and its association with 1,25-dihydroxyvitamin D3 in patients with Graves disease in an Egyptian population: a pilot study. Endocr. Pract. 18, 132–139 (2012)CrossRefGoogle Scholar
  14. 14.
    S. Kivity, N. Agmon-Levin, M. Zisappl, Y. Shapira, E.V. Nagy, K. Dankó, Z. Szekanecz, P. Langevitz, Y. Shoenfeld, Vitamin D and autoimmune thyroid diseases. Cell. Mol. Immunol. 8, 243–247 (2011)CrossRefPubMedGoogle Scholar
  15. 15.
    M.A. Pani, K. Regulla, M. Segni, S. Hofmann, M. Hüfner, A.M. Pasquino, K.H. Usadel, K. Badenhoop, A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab. 87, 2564–2567 (2002)PubMedGoogle Scholar
  16. 16.
    Y. Ban, Y. Ban, M. Taniyama, T. Katagiri, Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 10, 375–380 (2000)CrossRefPubMedGoogle Scholar
  17. 17.
    A. Maalej, E. Petit-Teixeira, G. Chabchoub, M. Ben Hamad, A. Rebai, N.R. Farid, F. Cornelis, H. Ayadi, Lack of association of VDR gene polymorphisms with thyroid autoimmune disorders: familial and case/control studies. J. Clin. Immunol. 28, 21–25 (2008)CrossRefPubMedGoogle Scholar
  18. 18.
    D.F. Stroup, J.A. Berlin, S.C. Morton, I. Olkin, G.D. Williamson, D. Rennie, D. Moher, B.J. Becker, T.A. Sipe, S.B. Thacker, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283, 2008–2012 (2000)CrossRefPubMedGoogle Scholar
  19. 19.
    A. Stang, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25, 603–605 (2010)CrossRefPubMedGoogle Scholar
  20. 20.
    C. Xu, H. Zhou, M. Gu, Vitamin D receptor (VDR) gene polymorphisms and Graves' disease: a meta-analysis. Clin. Endocrinol. (Oxf.). 70, 938–945 (2009)CrossRefPubMedGoogle Scholar
  21. 21.
    M. Feng, H. Li, S.F. Chen, W.F. Li, F. Bin Zhang, Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases: a meta-analysis. Endocrine 43, 318–326 (2013)CrossRefPubMedGoogle Scholar
  22. 22.
    X.-R. Gao, Y.-G. Yu, Meta-analysis of the association between Vitamin D receptor polymorphisms and the risk of autoimmune thyroid disease. Int. J. Endocrinol. 2018, 2846943 (2018)Google Scholar
  23. 23.
    M.Y. Xu, B. Cao, J. Yin, D.F. Wang, K.L. Chen, Q. Bin Lu, Vitamin D and Graves' disease: a meta-analysis update. Nutrients 7, 3813–3827 (2015)CrossRefPubMedGoogle Scholar
  24. 24.
    J.H. White, Vitamin D metabolism and signaling in the immune system. Rev. Endocr. Metab. Disord. 13, 21–29 (2012)CrossRefPubMedGoogle Scholar
  25. 25.
    F. Baeke, T. Takiishi, H. Korf, C. Gysemans, C. Mathieu, Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10, 482–496 (2010)CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Endocrinology and DiabetesHippokration General Hospital of ThessalonikiThessalonikiGreece
  2. 2.1st University Department of OphthalmologyAristotle University of ThessalonikiThessalonikiGreece

Personalised recommendations